Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alistair Ring (Autor), Meghan Karuturi (Autor), Emily Nash Smyth (Autor), Tasneem Lokhandwala (Autor), Kristin M. Sheffield (Autor), Joanne Willey (Autor), Orsolya Lunacsek (Autor), Francisco Sapunar (Autor), Zhanglin Lin Cui (Autor), Anna D. Coutinho (Autor), Sarah Rybowski (Autor)
Formato: Libro
Publicado: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible